WebJan 19, 2024 · 382 Background: Capecitabine is usually used for patients with curatively resected biliary tract cancer (BTC) in EU and US, but no clear survival benefit has been shown in phase III trials. S-1, an oral fluoropyrimidine derivative, has shown promising efficacy, with a mild toxicity profile, in patients with advanced BTC. The aim of this trial … WebFeb 27, 2015 · In summary, we developed a nomogram that predicts individual 5-year survival in patients who underwent curative resection for gastric cancer. This nomogram …
Curative resection - definition - English
WebSelect search scope, currently: articles+ all catalog, articles, website, & more in one search; catalog books, media & more in the Stanford Libraries' collections; articles+ journal articles & other e-resources WebFeb 24, 2010 · Background: The effectiveness of specific regimens of adjuvant therapy for gastric cancer has not been verified by large clinical trials. Recently, several large trials attempted to verify the effectiveness of adjuvant therapy. The Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer in Japan, a randomized controlled trial of adjuvant S-1 … cycloplegics and mydriatics
Evaluation of Comparative Surveillance Strategies of Circulating
WebMar 8, 2024 · Recurrence-Free Survival in Patients With Resected Colorectal Cancer View LargeDownload Surveillance strategies that were compared include a circulating tumor DNA (ctDNA) assay (Signetera; Natera), imaging, and imaging combined with measurement of carcinoembryonic antigen (imaging/CEA) levels. (A) ctDNA vs imaging, P= .45. WebWe aimed to design an effective and comprehensive nomogram to predict prognosis in very young patients with curatively resected BC. Methods: Female patients with a diagnosis of BC aged ≤ 35 years at presentation were identified from … WebJan 21, 2024 · Although adjuvant capecitabine has been recognized as the standard of care for curatively resected BTC, it does not improve OS compared with surgery alone, noted Masafumi Ikeda, MD, PhD, of National Cancer Center Hospital East in Kashiwa, Japan, who presented the phase 3 results at the meeting. cyclopithecus